Papers

3

Total Citations

54

H-Index

3

About

Philippe Coucke is a leading figure in radiation oncology, with a focused expertise in stereotactic body radiotherapy (SBRT) and robotic radiosurgery. His major contributions center on the clinical application and technical refinement of CyberKnife-based treatments for oligometastatic disease. Coucke’s work has been pivotal in demonstrating the safety and efficacy of robotic SBRT for challenging tumor sites, particularly in the liver and lung. His 2017 study on stereotactic robotic body radiotherapy for unresectable hepatic oligorecurrence (20 citations) established a critical treatment pathway for patients with limited liver metastases, while his analysis of 130 patients with primary and secondary lung tumors (19 citations) provided robust clinical outcomes data for lung SBRT. Beyond clinical results, Coucke has advanced the field’s technical precision, as shown in his work on commissioning Monte Carlo algorithms for robotic radiosurgery using cylindrical 3D arrays (15 citations), which improved dose calculation accuracy. His research bridges the gap between cutting-edge technology and tangible patient benefit, making him a key contributor to modern, non-invasive cancer care.

Research Focus

Key Achievements

3
H-Index
3
Papers
54
Total Citations
18
Avg Citations/Paper
🏆 Most Cited Paper
Stereotactic Robotic Body Radiotherapy for Patients With Unresectable Hepatic Oligorecurrence
20 citations · 2017
📈 Most Prolific Year: 2017 (3 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: University of Liège, Centre Hospitalier Universitaire de Liège

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago